SCHEMBL8306497

SCHEMBL8306497

c1ccc(CC2COC(N3CCN(Cc4ccsc4)CC3)CO2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.42
ALDH1A1 P00352 5/20 0.41
ITGA4 P13612 1/20 0.38
ITGB7 P26010 1/20 0.38
KDM1A O60341 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
OPRL1 P41146 1/20 0.38
CCR3 P51677 1/20 0.37
KDM4E B2RXH2 2/20 0.37
KMT2A Q03164 1/20 0.37
MC4R P32245 1/20 0.37
CHRM2 P08172 2/20 0.36
CHRM3 P20309 2/20 0.36
CHRM1 P11229 1/20 0.36
HTR1A P08908 1/20 0.36
HCRTR1 O43613 1/20 0.36
THRB P10828 1/20 0.36
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8303871 0.89 OPRM1 (0.42) SIGMAR1OPRM1OPRD1OPRK1CCR3
SCHEMBL8303201 0.87 SIGMAR1 (0.43) SIGMAR1OPRM1OPRD1OPRK1CCR3
SCHEMBL8303556 0.86 SIGMAR1 (0.43) SIGMAR1OPRM1OPRD1OPRK1CCR3
SCHEMBL8304636 0.76 OPRM1 (0.41) OPRM1OPRD1OPRK1CCR3CHRM2
SCHEMBL8303444 0.76 SIGMAR1 (0.55) SIGMAR1CCR3KMT2A
SCHEMBL9179397 0.74 SIGMAR1 (0.55) SIGMAR1HTR1A
SCHEMBL8691572 0.74 GRM2 (0.35) SIGMAR1HTR1A
SCHEMBL6609808 0.74 SIGMAR1 (0.41) SIGMAR1KMT2A
SCHEMBL2688223 0.73 GRIN2B (0.55) SIGMAR1ALDH1A1KDM4EKMT2AHTR1A
Hydrochloric Acid SCHEMBL9466555 0.73 SIGMAR1 (0.41) SIGMAR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0574313-B1 1,4-Disubstituted piperazines for the treatment of disorders of the central nervous system and neuro-endocrine disorders ADIR (FR) 1999-10-06 EP disclosed
US-5464834-A Antidepressants, central nervous system ADIR ET COMPAGNIE (FR) 1995-11-07 US disclosed
EP-0574313-A1 1,4-Disubstituted piperazines for the treatment of disorders of the central nervous system and neuro-endocrine disorders ADIR ET COMPAGNIE (FR) 1993-12-15 EP disclosed